TGTeresa González

Teresa González

*This is an algorithmically generated author record based on publicly available information.

Teresa González has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Caracterización estructural de aminoácidos 1-amino-1-cicloalcano carboxílicos

    by Patricia Tirado, Asiloé J. Mora, Teresa González, Jines Contreras, Gerzon Delgado

    Los aminoácidos no-proteinogénicos 1-amino-1-cicloalcano carboxílicos del tipo Accn, con n = 3, 4, 5, y 6, han sido recristalizados y caracterizados mediante las técnicas de espectroscopia FT-IR, análisis térmico (TGA-DSC), difracción de rayos-X en muestras policristalinas (XRPD) y cristal único (XRD). Los resultados espectroscópicos son consistentes con los grupos funcionales amino y ácido presentes en la familia de aminoácidos. El análisis térmico confirma la presencia de agua de cristalización en los aminoácidos Acc3, Acc4, y Acc5. Los patrones de difracción de rayos-X en polvo confirman la pureza de las muestras cristalinas. El análisis por difractometría de cristal único del aminoácido 1-amino-1-ciclopentano carboxílico Acc5, indica que el compuesto cristaliza en el grupo espacial monoclínico P21/c (N°14), en forma de zwiterión al igual que los demás aminoácidos. El empaquetamiento cristalino se estabiliza mediante la formación de interacciones intermoleculares del tipo de enlace de hidrógeno N--H···O y O--H···O entre moléculas vecinas y moléculas de agua de cristalización. Estos enlaces de hidrógeno dan lugar a la formación de estructuras supramoleculares formando anillos de 8 y 12 miembros descritas por en los grafos R2 4(8) y R4 4(12), respectivamente.

  • Open Access

    Síntesis y caracterización estructural del compuesto hidantoína de D,L-valina

    by Ronald Márquez, Lusbely M. Belandria, Marilia Guillén, Teresa González, Asiloé J. Mora, Gerzon Delgado

    La hidantoína de D,L-vailna, un nuevo derivado hidantóico de aminoácido, con fórmula C6H10N2O2, ha sido sintetizado y caracterizado estructuralmente mediante las técnicas IR, RMN, y difracción de rayos-X. Los resultados espectroscópicos son consistentes con el esqueleto molecular. El patrón de difracción de rayos-X en polvo confirma la pureza de la muestra cristalina. El análisis por difractometría de cristal único indica que el compuesto cristaliza en el sistema monoclínico, grupo espacial P21/c (Nº14), con parámetros de celda unidad: a= 5,493(3) Å, b= 23,53(2) Å, c= 6,254(3) Å y β= 115,09(4)º, V= 732,1(9) Å3, Z= 4. El empaquetamiento cristalino está estabilizado por enlaces de hidrógeno fuertes del tipo N--H···O entre los anillos hidantoínicos vecinos; formando los grafos: C(5), R22(8) y R44(16). Además, la estructura cristalina presenta en-laces de hidrógeno no convencionales del tipo C5--H5···O2 e interacciones entre los bordes del anillo hidantoína. La interacción de todos estos tipos de enlaces de hidrógeno, junto a fuerzas dispersivas presentes en las regiones donde se encuentran los grupos isopropilos, estabilizan el eficiente empaquetamiento de la estructura con un índice de espacio ocupado de 66,3%.

  • Open Access

    SOLVENT-FREE SYNTHESIS AND CRYSTAL STRUCTURE OF rac-2-THIOHYDANTOIN-VALINE

    by G. E. Delgado, Asiloé J. Mora, T. González, I. Santos, P. Rivas, L. E. Seijas

    Thiohydantoins have been used in the manufacture of medicines and in industrial processes. Depending on the nature and type of substitution on the heterocyclic ring, these compounds may display pharmaceutical and biological activity with a variety of applications as antiepileptic, antitumoral, antiinflammatory, and principally for the treatment of prostate cancer. In this study, a new thiohydantoin was synthetized from the valine amino acid and structurally characterized. The title compound, C6H10N2O2S, with systematic name rac-5-isopropyl-2-tioxoimidazolidin-4-one, has been synthetized by a solvent-free synthesis. The heterocyclic compound was characterized by spectroscopic infrared (FTIR) and nuclear magnetic resonance (NMR) techniques, powder and single-crystal X-ray diffraction analysis (XRD). This material crystallizes in the monoclinic space group P21/c. In the supramolecular structure, the molecules are joined by N- --H···O and N---H···S hydrogen bonds, forming centrosymmetric R2 2(8) dimers and C2 2(9) chains that run along the [001] direction in an infinite one-dimensional network.

  • Open Access

    Reactivity of dirhenium and triruthenium carbonyls toward a biphosphole ligand: M–M, P–P and C–H bonds cleavage

    by Yomaira Otero, David Coll, Alejandro Arce, Deisy Peña, Franmerly Fuentes, Muriel Hissler, Regis Réau, Rubén Machado, Teresa Gonzalez, Edward Ávila


  • Open Access

    A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia

    by José Ángel Hernández, María Hernández-Sánchez, Ana Eugenia Rodríguez-Vicente, Vera Grossmann, Rosa Collado, Cecilia Heras, Anna Puiggros, Ana África Martín, Noemí Puig, Rocío Benito, et al.

    To analyze the impact of the 11q deleted (11q-) cells in CLL patients on the time to first therapy (TFT) and overall survival (OS), 2,493 patients with CLL were studied. 242 patients (9.7%) had 11q-. Fluorescence in situ hybridization (FISH) studies showed a threshold of 40% of deleted cells to be optimal for showing that clinical differences in terms of TFT and OS within 11q- CLLs. In patients with ≥40% of losses in 11q (11q-H) (74%), the median TFT was 19 months compared with 44 months in CLL patients with PIGHV status, early Binet stage and absence of extended lymphadenopathy were associated with longer TFT. Patients with 11q-H had an OS of 90 months, while in the 11q-L group the OS was not reached (P = 0.008). The absence of splenomegaly (P = 0.02), low LDH (P = 0.018) or β2M (P = 0.006), and the presence of 11q-L (P = 0.003) were associated with a longer OS. In addition, to detect the presence of mutations in the ATM, TP53, NOTCH1, SF3B1, MYD88, FBXW7, XPO1 and BIRC3 genes, a select cohort of CLL patients with losses in 11q was sequenced by next-generation sequencing of amplicons. Eighty % of CLLs with 11q- showed mutations and fewer patients with low frequencies of 11q- had mutations among genes examined (50% vs 94.1%, P = 0.023). In summary, CLL patients with <40% of 11q- had a long TFT and OS that could be associated with the presence of fewer mutated genes.


  • Open Access

    Hydrogen bond patterns in 3-carboxypiperidinium semi-oxalatemonohydrate

    by Lusbely M. Belandria, Asiloé J. Mora, Teresa González, Gerzon Delgado

    The crystal structure of compound C6H12NO2+·C2HO4−·H2O, or NIPE+·OXAL−·HYDR, is an ionic ensemble assisted by hydrogen bonds established between NIPE+ cations, OXAL− semi-oxalate anions and water molecules. The molecules are connected by O--H···O and N--H···O hydrogen bonds, forming linear ∙∙∙semi-oxalate∙∙∙semi-oxalate∙∙∙ chains extending along the a axis and described by the graph-set motif C(5). These chains interact with the NH2+ group of NIPE+ and the water molecules building a two-dimensional crystal packing of rings described by graph-set R21(5), R24(8) and R55(19), with corrugated layers running parallel to the (001) plane, and separated by hydrophobic interactions at c/2. Analyzes of the structures of the individual components and the hydrogen-bond network of the crystal structure are given.